Insights

Innovative Therapeutics Acurex Biosciences has developed a platform targeting neurodegenerative diseases with a focus on Parkinson's, offering potential for partnerships or licensing opportunities in neurotherapeutics and biomarker discovery technologies.

Funding & Growth With over 18 million dollars in seed funding from prominent institutions like Stanford University and the Michael J. Fox Foundation, there is strong investor confidence that can support advanced research collaborations and clinical development partnerships.

Research Collaborations Supported by leading academic and research foundations, Acurex presents opportunities for technology licensing, joint ventures, and research collaborations to expand therapeutic pipelines in neurodegeneration.

Strategic Appointments The recent appointment of industry expert Robert Booth to the board indicates strategic growth potential, opening doors for networking, strategic partnerships, and investor engagement within the biotech sector.

Market Penetration As a biotech with a focus on blood-brain barrier crossing small molecule therapeutics and early clinical development, Acurex offers opportunities for pharmaceutical companies seeking innovative drug delivery or pipeline expansion in neurodegeneration.

Acurex Biosciences Tech Stack

Acurex Biosciences uses 8 technology products and services including WordPress, Lodash, WP Engine, and more. Explore Acurex Biosciences's tech stack below.

WordPress

Content Management System

Lodash

Javascript Libraries

WP Engine

Platform As A Service

PHP

Programming Languages

reCAPTCHA

Security

X-XSS-Protection

Security

X-Content-Type-Options

Web & Portal Technology

Google Analytics

Web Analytics

Acurex Biosciences Email Formats	Example	Percentage
First.Last@acurex.com	John.Doe@acurex.com	50%
First.Last@acurex.com	John.Doe@acurex.com	50%

Acurex Biosciences Email Formats

Example

Percentage

First.Last@acurex.com

John.Doe@acurex.com

50%

First.Last@acurex.com

John.Doe@acurex.com

50%

Frequently Asked Questions

Where is Acurex Biosciences's headquarters located?

Acurex Biosciences's main headquarters is located at San Carlos, California 94070 United States. The company has employees across 1 continents, including North America.

What is Acurex Biosciences's official website and social media links?

Acurex Biosciences's official website is acurex.com and has social profiles on LinkedIn.

What is Acurex Biosciences's SIC code NAICS code?

Acurex Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Acurex Biosciences have currently?

As of March 2026, Acurex Biosciences has approximately 13 employees across 1 continents, including North America. Key team members include Owner: M. P.Vice President, Biology: S. P.Senior Scientist: C. H.. Explore Acurex Biosciences's employee directory with LeadIQ.

What industry does Acurex Biosciences belong to?

Acurex Biosciences operates in the Biotechnology Research industry.

What technology does Acurex Biosciences use?

Acurex Biosciences's tech stack includes WordPressLodashWP EnginePHPreCAPTCHAX-XSS-ProtectionX-Content-Type-OptionsGoogle Analytics.

What is Acurex Biosciences's email format?

Acurex Biosciences's email format typically follows the pattern of First.Last@acurex.com. Find more Acurex Biosciences email formats with LeadIQ.

Acurex Biosciences

Q: What is Acurex Biosciences's official website and social media links?

Acurex Biosciences's official website is acurex.com. Acurex Biosciences has social profiles on LinkedIn.

Q: How many employees does Acurex Biosciences have currently?

Acurex Biosciences has approximately 13 employees.

Q: What technology does Acurex Biosciences use?

Acurex Biosciences's tech stack includes jQuery, Bootstrap, MySQL, Open Graph, React.

Q: What is Acurex Biosciences's NAICS code?

Acurex Biosciences's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States11-50 Employees

𝗔𝗰𝘂𝗿𝗲𝘅'𝘀 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗶𝘀 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝘁𝗵𝗮𝘁 𝗳𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹𝗹𝘆 𝗺𝗼𝗱𝗶𝗳𝘆 𝘁𝗵𝗲 𝗰𝗼𝘂𝗿𝘀𝗲 𝗼𝗳 𝗻𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀, 𝗮𝗶𝗺𝗶𝗻𝗴 𝗻𝗼𝘁 𝗷𝘂𝘀𝘁 𝘁𝗼 𝘁𝗿𝗲𝗮𝘁 𝘁𝗵𝗲 𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝘀 𝗯𝘂𝘁 𝘁𝗼 𝘀𝗹𝗼𝘄 𝗼𝗿 𝘀𝘁𝗼𝗽 𝘁𝗵𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲’𝘀 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻.

Acurex’s platform and founding intellectual property are based on a Stanford University breakthrough discovery enabling the identification of druggable targets that induce biomarker changes in Parkinson's disease. Acurex’s platform has generated two oral small-molecule therapeutic programs that cross the blood-brain barrier and protect  neurons derived from Parkinson’s disease patients. Acurex’s lead program has begun IND-enabling studies, and the second program to a distinct target is in lead development. 

Acurex is supported by funding from Stanford University, the University of California, the Michael J. Fox Foundation for Parkinson’s Research, Parkinson’s UK, The Silverstein Foundation for Parkinson’s with GBA, and the National Institute on Aging.

Insights

Similar companies to Acurex Biosciences

QIAGEN

Bio-Rad Laboratories

Roche

Danaher Corporation

Sartorius

Merck

Bruker

Thermo Fisher Scientific

Agilent Technologies

Illumina

PerkinElmer, Inc.